U.S. Markets open in 1 hr 14 mins
S&P Futures
3,659.75+36.50(+1.01%)Dow Futures
29,947.00+318.00(+1.07%)Nasdaq Futures
12,394.50+117.50(+0.96%)
AVEO Pharmaceuticals, Inc. (AVEO)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
5.38-0.03 (-0.55%)
At close: 4:00PM EST
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 5.41 |
| Open | 5.42 |
| Bid | 5.15 x 900 |
| Ask | 6.64 x 1100 |
| Day's Range | 5.21 - 5.46 |
| 52 Week Range | 2.23 - 10.71 |
| Volume | 420,428 |
| Avg. Volume | 429,323 |
| Market Cap | 154.994M |
| Beta (5Y Monthly) | 1.54 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.52 |
| Earnings Date | Nov 09, 2020 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 11.25 |
- Business Wire
AVEO Oncology to Present at the Stifel 2020 Virtual Healthcare Conference
AVEO Oncology (Nasdaq: AVEO) today announced that Michael Bailey, president and chief executive officer of AVEO, will present at the Stifel 2020 Virtual Healthcare Conference on Monday, November 16, 2020 at 11:20 a.m. Eastern Time.
- Zacks
AVEO Pharmaceuticals (AVEO) Reports Q3 Loss, Lags Revenue Estimates
AVEO (AVEO) delivered earnings and revenue surprises of -37.50% and -5.39%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
- Business Wire
AVEO Oncology Reports Third Quarter 2020 Financial Results and Provides Business Update
AVEO Oncology (Nasdaq: AVEO) today reported financial results for the third quarter ended September 30, 2020 and provided a business update.
© 2020 Verizon Media. All rights reserved.
